Screening for primary aldosteronism

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 20, Issue 3, 2006, Pages 369-384

  Schirpenbach, Caroline ^b   Reincke, Martin ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b NONE

Author keywords

aldosterone; Conn's syndrome; primary aldosteronism; renin; secondary hypertension

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUDROCORTISONE; GLUCOCORTICOID; LOSARTAN; POTASSIUM; RENIN; SODIUM CHLORIDE;

ADRENAL CORTEX ADENOMA; ADRENAL GLAND; ADRENAL HYPERPLASIA; ADRENAL SCINTISCANNING; ADRENALECTOMY; BLOOD SAMPLING; BODY POSTURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; DRUG WITHDRAWAL; ECHOGRAPHY; ENDOCRINE FUNCTION TEST; FLUDROCORTISONE SUPPRESSION TEST; HEALTH CARE COST; HORMONE DETERMINATION; HUMAN; HYPERTENSION; HYPOKALEMIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PATIENT SELECTION; PRIMARY HYPERALDOSTERONISM; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; VENOUS BLOOD;

ALDOSTERONE; ALGORITHMS; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; POTASSIUM; PREVALENCE; RENIN;

EID: 33748490714     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beem.2006.07.007     Document Type: Review

References (99)

1. Conn J. Presidential address. Part II. Primary aldosteronism, a new clinical syndrome. The Journal of Laboratory and Clinical Medicine 45 (1955) 6-17
2. Mulatero P., Dluhy R., Giacchetti G., et al. Diagnosis of primary aldosteronism: from screening to subtype differentiation. Trends in Endocrinology and Metabolism 16 3 (2005) 114-119
3. Reincke M., Seiler L., and Rump L.C. Normokaliämischer primärer Hyperaldosteronismus. Deutsches Ärzteblatt 100 4 (2003) A184-A190
4. Gordon R., Klemm S., Stowasser M., et al. How common is primary aldosteronism? Is it the most frequent form of curable hypertension?. Journal of Hypertension 11 supplement 5 (1993) S310-S311
5. Benchetrit S., Bernheim J., and Podjarny E. Normokalemic hyperaldosteronism in patients with resistant hypertension. The Israel Medical Association Journal 4 (2002) 17-20
6. Wolf-Maier K., Cooper R., Banegas J., et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. The Journal of the American Medical Association 289 18 (2003) 2363-2369
7. Delcayre C., Silvestre J., Garnier A., et al. Cardiac aldosterone production and ventricular remodeling. Kidney International 57 (2000) 1346-1351
8. Rocha R., and Funder J. The pathophysiology of aldosterone in the cardiovascular system. Annals of the New York Academy of Sciences 970 (2002) 89-100
9. Matsumura K., Fujii K., Ioniki H., et al. Role of aldosterone in left ventricular hypertrophy in hypertension. American Journal of Hypertension 19 1 (2006) 23-28
10. Rossi G., Sacchetto A., Visentin P., et al. Changes in left ventricular anatomy and function in hypertension and primary aldosteronism. Hypertension 27 (1996) 1039-1045
11. Pitt B., Zannad F., Remme W., et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. The New England Journal of Medicine 341 19 (1999) 709-717
12. Pitt B., Remme W., Zannad F., et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. The New England Journal of Medicine 348 (2003) 1309-1321
13. Mulatero P., Stowasser M., Loh K., et al. Increased diagnosis of primary aldosteronism including surgically correctable forms in centers from five continents. The Journal of Clinical Endocrinology and Metabolism 89 (2004) 1045-1050
14. Seiler L., Rump L., Borm K., et al. Prevalence of primary hyperaldosteronism in a university hypertension outpatient clinic: is it underdiagnosed?. Experimental and Clinical Endocrinology & Diabetes 110 supplement 1 (2002) S84
15. Conn J., and Lawrence H. Primary aldosteronism, a new clinical entity. Annals of Internal Medicine 44 1 (1956) 1-15
16. Fallo F., Veglio F., Bertello C., et al. Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. The Journal of Clinical Endocrinology and Metabolism 91 2 (2006) 454-499
17. Ganguly A. Primary aldosteronism. The New England Journal of Medicine 25 (1998) 1828-1834
18. Mosso L., Carvajal C., Gonzales A., et al. Primary aldosteronism and hypertensive disease. Hypertension 42 (2003) 161-165
19. Vantyghem M., Ronci N., Provost F., et al. Aldosterone-producing adenoma without hypertension: a report of two cases. European Journal of Endocrinology 141 3 (1999) 279-285
20. Irony I., Kater C.E., Biglierir E.G., et al. Correctable subsets of primary aldosteronism. Primary adrenal hyperplasia and renin responsive adenoma. American Journal of Hypertension 3 (1990) 576-582
21. Stowasser M., and Gordon R. Familial hyperaldosteronism. The Journal of Steroid Biochemistry and Molecular Biology 78 (2001) 215-229
22. Luton J., Cerdas S., Billaud L., et al. Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. The New England Journal of Medicine 322 17 (1990) 1195-1201
23. Allolio B., Fassnacht M., and Arlt W. Maligne Tumoren der Nebennierenrinde. Internist 43 (2002) 186-195
24. Blumenfeld J., Sealey J., Schlussel Y., et al. Diagnosis and treatment of primary hyperaldosteronism. Annals of Internal Medicine 121 11 (1994) 877-885
25. Padfield P. Prevalence and role of a raised aldosterone to renin ratio in the diagnosis of primary aldosteronism: a debate on the scientific logic of the use of the ratio in practice. Clinical Endocrinology 59 (2003) 422-426
26. Anonymous. Idiopathic aldosteronism - a diagnostic artifact?. Lancet 2 (1979) 1221-1222
27. Gordon R., Stowasser M., Klemm S., et al. Primary aldosteronism - some genetic, morphological, and biochemical aspects of subtypes. Steroids 60 (1995) 35-41
28. Fallo F., Barzon L., Biasi F., et al. Zona fasciculata-like histotype and aldosterone response to upright posture are not related in aldosterone-producing adenomas. Experimental and Clinical Endocrinology & Diabetes 106 (1998) 74-78
29. Fontes R., Kater C., Biglieri E., et al. Reassessment of the predictive value of the postural stimulation test in primary aldosteronism. American Journal of Hypertension 4 (1991) 786-791
30. Stowasser M., Gordon R., Gunasekera T., et al. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients. Journal of Hypertension 21 (2003) 2149-2157
31. Fardella C., Mosso L., Gómez-Sánchez C., et al. Primary aldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. The Journal of Clinical Endocrinology and Metabolism 85 5 (2000) 1863-1867
32. Lim P., Rodgers P., Cardale K., et al. Potentially high prevalence of primary aldosteronism in a primary-care population. Lancet 353 (1999) 40
33. Loh K., Koay E., Khaw M., et al. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. The Journal of Clinical Endocrinology and Metabolism 85 (2000) 2854-2859
34. Williams J., Williams G., Raji A., et al. Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia. Journal of Human Hypertension 20 2 (2006) 129-136
35. Plouin P., Amar L., and Chatellier G. Trends in the prevalence of primary aldosteronism, aldosterone-producing adenomas, and surgically correctable aldosterone-dependent hypertension. Nephrology, Dialysis, Transplantation 19 (2004) 774-777
36. Rossi E., Regolisti G., Negro A., et al. High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives. American Journal of Hypertension 15 (2002) 896-902
37. Mosso L., Fardella C., Montero J., et al. High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension. Revista Médica de Chile 127 7 (1999) 800-806
38. Rayner B., Opie L., and Davidson J. The aldosterone/renin ratio as a screening test for primary aldosteronism. South African Medical Journal 90 4 (2000) 394-400
39. Kaplan N.M. The current epidemic of primary aldosteronism: causes and consequences. Journal of Hypertension 22 5 (2004) 863-869
40. Kaplan N.M. The current epidemic of primary aldosteronism: causes and consequences. Journal of Hypertension 22 10 (2004) 2040 [Author reply]
41. Dluhy R., and Williams G. Aldosterone - villain or bystander?. The New England Journal of Medicine 351 1 (2004) 8-10
42. Kaplan N. Cautions over the current epidemic of primary aldosteronism. Lancet 357 (2001) 953-954
43. Sywak M., and Pasieka J. Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism. The British Journal of Surgery 89 (2002) 1587-1593
44. McKenna T., Sequeira S., Heffernan A., et al. Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary aldosteronism. The Journal of Clinical Endocrinology and Metabolism 73 (1991) 952-957
45. Spence J.D. The current epidemic of primary aldosteronism: causes and consequences. Journal of Hypertension 22 10 (2004) 2038-2039
46. Tiu S., Choi C., Shek C., et al. The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling. The Journal of Clinical Endocrinology and Metabolism 90 1 (2005) 72-78
47. Hiramatsu K., Yamada T., Yukimura Y., et al. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Archives of Internal Medicine 141 (1981) 1589-1593
48. Lim P., and MacDonald T. Primary aldosteronism, diagnosed by the aldosterone to renin ratio, is a common cause of hypertension. Clinical Endocrinology 59 (2003) 427-430
49. Gordon R. The challenge of more robust and reproducible methodology in screening for primary aldosteronism. Journal of Hypertension 22 (2004) 251-255
50. Schwartz G., Chapman A., Boerwinkle E., et al. Screening for primary aldosteronism: implications of an increased plasma aldosterone/renin ratio. Clinical Chemistry 48 11 (2002) 1919-1923
51. Schwartz G., and Turner S. Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity. Clinical Chemistry 51 2 (2005) 386-394
52. Connell J., and Fraser R. Primary aldosteronism. In: Wass J., and Shalet S. (Eds). The Oxford Textbook of Endocrinology and Diabetes (2002), Oxford University Press, Oxford 791-799
53. Seiler L., Rump L., Schulte-Mönting J., et al. Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication. European Journal of Endocrinology 150 (2004) 329-337
54. Tanabe A., Naruse M., Takagi S., et al. Variability in the renin/aldosterone profile under random and standardized sampling conditions in primary aldosteronism. The Journal of Clinical Endocrinology and Metabolism 88 6 (2003) 2489-2494
55. Stowasser M., and Gordon R. Prevalence and diagnostic workup of primary aldosteronism: new knowledge and new approaches. Nephrology 6 (2001) 119-126
56. Gallay B., Ahmad S., Xu L., et al. Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio. American Journal of Kidney Diseases 37 4 (2001) 699-705
57. Seifarth C., Trenkel S., Schobel H., et al. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism. Clinical Endocrinology 57 (2002) 457-465
58. Nadler J., Hsueh W., and Horton R. Therapeutic effect of calcium channel blockade in primary aldosteronism. The Journal of Clinical Endocrinology and Metabolism 60 (1985) 896-899
59. Montori V., and Young W.J. Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature. Endocrinology and Metabolism Clinics of North America 31 3 (2002) 619-632
60. Montori V., Schwartz G., Chapman A., et al. Validity of the aldosterone-renin ratio used to screen for primary aldosteronism. Mayo Clinic Proceedings 76 (2001) 877-882
61. Auchus R. Aldo is back: recent advances and unresolved controversies in hyperaldosteronism. Current Opinion in Nephrology and Hypertension 12 2 (2003) 153-158
62. Cartledge S., and Lawson N. Aldosterone and renin measurements. Annals of Clinical Biochemistry 37 (2000) 262-278
63. Sealey J.E., Blumenfeld J., and Laragh J.H. Prorenin cryoactivation as a possible cause of normal renin levels in patients with primary aldosteronism. Journal of Hypertension 23 2 (2005) 459-460
64. Perschel F., Schemer R., Seiler L., et al. Rapid screening test for primary aldosteronism: ratio of plasma aldosterone to renin concentration determined by fully automated chemiluminescence immunoassays. Clinical Chemistry 50 9 (2004) 1650-1655
65. Brown M., Cramp H., Zammit V., et al. Primary hyperaldosteronism: a missed diagnosis in 'essential hypertensives'?. Australian and New Zealand Journal of Medicine 4 (1996) 533-538
66. Trenkel S., Seifarth C., Schobel H., et al. Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism. Experimental and Clinical Endocrinology & Diabetes 110 (2002) 80-85
67. Olivieri O., Ciacciarelli A., Signorelli D., et al. Aldosterone to renin ratio in a primary care setting: the bussolengo study. The Journal of Clinical Endocrinology and Metabolism 89 (2004) 4221-4226
68. Ferrari P., Shaw S., Nicod J., et al. Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism. Journal of Hypertension 22 (2004) 377-381
69. Unger N., Lopez Schmidt I., and Pitt C. Comparison of active renin concentration and plasma renin activity for the diagnosis of primary hyperaldosteronism in patients with an adrenal mass. European Journal of Endocrinology 150 (2004) 517-523
70. Mantero F., Bedendo O., and Opocher G. Does dynamic testing have a place in the modern assessment of endocrine hypertension?. Journal of Endocrinological Investigation 26 supplement 7 (2003) 92-98
71. Stowasser M., Gordon R., Rutherford J., et al. Diagnosis and management of primary aldosteronism. Journal of the Renin-Angiotensin-Aldosterone System 2 (2001) 156-169
72. Kem D., Weinberger M., Mayes D., et al. Saline suppression of plasma aldosterone in hypertension. Archives of Internal Medicine 128 (1971) 380-386
73. Holland O., Brown H., von Kuhnert L., et al. Further evaluation of saline infusion for the diagnosis of primary aldosteronism. Hypertension 6 (1984) 717-723
74. Corvol P., Houde M., Benguigui L., et al. Le système rénine-angiotensine-aldostérone chez les sujets hypertendus. II. Le diagnostic de l'hyperaldostéronisme primaire. La Nouvelle Presse Médicale 6 29 (1977) 2569-2572
75. Gordon RD, Taylor WL, Rossetti TR et al. A prospective evaluation of definite tests for primary aldosteronism. 21st Annual Scientific Meeting, Melbourne Exhibition Centre, December 9-11, 1999. Program and Abstracts, published by High Blood Pressure Research Council of Australia Inc. ISSN 1329-105X.
76. Schirpenbach C., Seiler L., Maser-Gluth C., et al. Confirmatory testing in normokalaemic primary aldosteronism: the value of saline infusion test and urinary aldosterone metabolites. European Journal of Endocrinology 154 6 (2006) 865-873
77. Young W. Primary aldosteronism. Annals of the New York Academy of Sciences 970 (2002) 61-76
78. Bravo E., Tarazi R., Dustan H., et al. The changing clinical spectrum of primary aldosteronism. American Journal of Medicine 74 (1983) 641-651
79. Agharazii M., Douville P., Grose J., et al. Captopril suppression versus salt loading in confirming primary aldosteronism. Hypertension 37 (2001) 1440-1443
80. Castro O., Yu X., and Kern D. Diagnostic value of the post-Captopril test in primary aldosteronism. Hypertension 39 (2002) 935-938
81. Abdelhamid S., Blomer R., Hommel G., et al. Urinary tetrahydroaldosterone as a screening method for primary aldosteronism: a comparative study. American Journal of Hypertension 16 (2003) 522-530
82. Gomez-Sanchez C., and Holland O. Urinary tetrahydroaldosterone and aldosterone-18-glucuronide excretion in white and black normal subjects and hypertensive patients. The Journal of Clinical Endocrinology and Metabolism 52 (1981) 214-219
83. Schirpenbach C., Seiler L., Maser-Gluth C., et al. Automated chemiluminescence-immunoassay for aldosterone during dynamic testing: comparison to radioimmunoassays with and without extraction steps. Clinical Chemistry 20 (2006) [Epub ahead of print]
84. Lingam R., Sohaib S., Vlahos I., et al. CT of primary hyperaldosteronism (Conn's syndrome): the value of measuring the adrenal gland. American Journal of Roentgenology 181 (2003) 843-849
85. Guest P. Adrenal imaging. In: Wass J., and Shalet S. (Eds). The Oxford Textbook of Endocrinology and Diabetes (2002), Oxford University Press, Oxford 747-756
86. Lingam R., Sohaib S., Rockall A., et al. Diagnostic performance of CT versus MR in detecting aldosterone-producing adenoma in primary hyperaldosteronism (Conn's syndrome). European Radiology 14 10 (2004) 1787-1792
87. Young W., Stanson A., Thompson G., et al. Role for adrenal venous sampling in primary aldosteronism. Surgery 136 6 (2004) 1227-1235
88. Magill S., Raff H., Shaker J., et al. Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism. The Journal of Clinical Endocrinology and Metabolism 86 (2001) 1066-1071
89. Stowasser M., and Gordon R. Primary aldosteronism: learning from the study of familial varieties. Journal of Hypertension 18 (2000) 1165-1176
90. Kann P., Hengstermann C., Heussel C., et al. Endosonography of the adrenal glands: normal size - pathological findings. Experimental and Clinical Endocrinology & Diabetes 106 2 (1998) 123-129
91. Kann P. Endoscopic ultrasound imaging of the adrenals. Endoscopy 37 3 (2005) 244-253
92. Vallotton M. Primary aldosteronism. Part II differential diagnosis of primary hyperaldosteronism and pseudoaldosteronism. Clinical Endocrinology 45 (1996) 53-60
93. Radin D., Manoogian C., and Nadler J. Diagnosis of primary hyperaldosteronism: importance of correlating CT findings with endocrinologic studies. American Journal of Roentgenology 158 3 (1992) 553-557
94. Sheaves R., Goldin J., Reznek R., et al. Relative value of computed tomography scanning and venous sampling in establishing the cause of primary aldosteronism. European Journal of Endocrinology 134 3 (1996) 308-313
95. Phillips J., Walther M., Pezzullo J., et al. Predictive value of preoperative tests in discriminating bilateral hyperplasia from an aldosterone-producing adenoma. The Journal of Clinical Endocrinology and Metabolism 85 12 (2000) 4526-4533
96. Doppman J., and Gill J. Hyperaldosteronism: sampling the adrenal veins. Radiology 198 (1996) 309-312
97. Young W., Stanson A., Grant C., et al. Primary aldosteronism: adrenal venous sampling. Surgery 120 (1996) 913-920
98. Rossi G., Sacchetto A., Chiesura-Corona M., et al. Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and manetic resonance findings: results in 104 consecutive cases. The Journal of Clinical Endocrinology and Metabolism 86 (2001) 1083-1090
99. Lyons D., Kem D., Brown R., et al. Single dose captopril as a diagnostic test for primary aldosteronism. The Journal of Clinical Endocrinology and Metabolism 57 (1983) 892-896